Breaking new ground in heart health: Lubdub’s clinical trials kick off

Project update: 19-11-25

Lubdub begins studies for non-invasive cardiac monitoring technologies

In collaboration with leading hospitals, research organisations, and community health cohorts, Lubdub is pioneering a suite of accessible, non-invasive tools designed to make heart diagnostics simpler, faster, and more equitable for everyone.

These innovations include:

• a wearable ECG patch that monitors heart rhythms continuously for up to two weeks,
• a saliva-based test that detects key cardiac biomarkers without a blood draw, and
• a wireless ultrasound device that captures heart images from home.

Together, they represent a leap forward in proactive, accessible care – transforming how heart disease is detected and managed.

From hospital to home: testing next-generation cardiac monitoring in metro health centres

The first stage of Lubdub’s studies is taking place across leading metropolitan healthcare centres, where clinicians are trialling the company’s new wearable ECG patch and saliva-based biomarker test with patients already undergoing cardiac evaluation.

The goal is simple - to compare Lubdub’s technologies directly against current hospital-grade diagnostics and determine whether patients can receive equally reliable results from more comfortable, lower-cost, and mobile solutions.

By embedding innovation within existing hospital workflows, the team is creating a blueprint for how advanced diagnostics can be integrated seamlessly into everyday clinical practice – without adding cost or complexity.

Reaching beyond the city: expanding access through community health studies

Following success in metro hospitals, Lubdub’s research is extending to community cohorts and regional health programs, where access to cardiac testing is often limited by geography and resources.

In these settings, the same technologies are being tested to understand their potential for remote and preventive use – allowing individuals to monitor their heart health from home or within their local community centre, rather than travelling long distances for specialist appointments.

These studies mark an important step in addressing the growing inequity between urban and regional healthcare.

By bringing hospital-grade diagnostics to the community, Lubdub is empowering clinicians and individuals alike to detect cardiac risk earlier, act sooner, and save lives.

Transforming emergency care: saliva testing for faster, safer diagnosis

The next frontier for Lubdub’s innovation lies in the emergency department, where time is everything. A new study is evaluating Lubdub’s saliva-based diagnostic device as a rapid triage tool for patients presenting with chest pain or shortness of breath – symptoms that could signal a heart attack, heart failure, infection, or blood clot.

The device can detect critical biomarkers (such as Troponin, BNP, CRP, and D-Dimer) in under ten minutes, all from a simple saliva sample. This eliminates the need for a blood draw, reducing delays and freeing up clinical staff to focus on the most urgent cases.

By enabling faster and more accurate decision-making, the technology has the potential to transform how emergency departments prioritise and manage patients – improving safety, efficiency, and outcomes for thousands of Australians each year.

As Lubdub and the Heart Foundation continue this journey, they share one powerful belief: that no life should be lost because healthcare was too complex, too late, or out of reach.

Read more